Inflammatory and Nutritional Markers Predicting Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Multicenter Real-World Study
Journal of Clinical Medicine · 15.10.2025 · 14 (20) · 7271
DOI: 10.3390/jcm14207271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.10.2025. Verfasst von Zeliha Birsin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul 34320, Türkiye. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pathological complete response (pCR) following neoadjuvant therapy (NAT) is a key surrogate marker for long-term outcomes in HER2-positive breast cancer. Identifying clinical and biological predictors of pCR, including systemic inflammatory and nutritional markers such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), neutrophil-to-albumin ratio (NAR), C-reactive protein-to-albumin ratio (CAR), systemic immune-inflammation index (SII), and prognostic nutritional index (PNI), may help refine treatment strategies and improve patient outcomes.
Methods
We retrospectively analyzed 174 patients with stage II–III HER2-positive breast cancer who received neoadjuvant anti-HER2-based regimens at multiple centers between 2010 and 2025. Demographic, clinicopathological, and laboratory data were collected, and inflammatory and nutritional indices (NLR, PLR, LMR, NAR, CAR, SII, PNI) were calculated. Predictors of pCR were evaluated using univariate and multivariate logistic regression analyses.
Results
Overall, 49% of patients achieved pCR. In multivariate analysis, independent predictors of pCR were hormone receptor negativity, smaller tumor size, HER2 IHC 3+ expression, dual HER2 blockade, and a higher prognostic nutritional index (PNI ≥ 55). In contrast, systemic inflammatory indices such as NLR, PLR, LMR, NAR, CAR, and SII were not significantly associated with pCR.
Conclusions
This multicenter real-world study demonstrates that conventional inflammatory markers have limited predictive value, whereas the PNI emerges as a simple and practical biomarker reflecting nutritional and immune status. Integrating PNI with clinicopathological factors may enhance risk stratification and help guide individualized neoadjuvant treatment strategies in HER2-positive breast cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul 34320, Türkiye.
- Department of Medical Oncology, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul 34722, Türkiye.
- Department of Medical Oncology, Faculty of Medicine, Bursa Uludağ University, Bursa 16059, Türkiye.
- Department of General Surgery, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul 34320, Türkiye.
- Department of Pathology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul 34320, Türkiye.
ORCID-Profile: İsmail Nazlı, Onur Alkan, Hülya Odabaşı Bükün, Murat Günaltılı, Seda Jeral, Hamza Abbasov, Türkkan Evrensel, Ceyda Sönmez Wetherilt, Özkan Alan
Zitieren
APA
Birsin, Z., Nazlı, İ., Alkan, O., Odabaşı Bükün, H., Günaltılı, M., Çerme, E., Aliyev, V., Cebeci, S., Jeral, S., Abbasov, H., Evrensel, T., Papila, Ç., Papila, B., Sönmez Wetherilt, C., Demirci, N. S., & Alan, Ö. (2025). Inflammatory and Nutritional Markers Predicting Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Multicenter Real-World Study. Journal of Clinical Medicine, 14(20), 7271. https://doi.org/10.3390/jcm14207271
Vancouver
Birsin Z, Nazlı İ, Alkan O, Odabaşı Bükün H, Günaltılı M, Çerme E, et al. Inflammatory and Nutritional Markers Predicting Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Multicenter Real-World Study. Journal of Clinical Medicine. 2025;14(20):7271. doi:10.3390/jcm14207271
BibTeX
@article{Birsin2025,
author = {Birsin, Zeliha and Nazlı, İsmail and Alkan, Onur and Odabaşı Bükün, Hülya and Günaltılı, Murat and Çerme, Emir and Aliyev, Vali and Cebeci, Selin and Jeral, Seda and Abbasov, Hamza and Evrensel, Türkkan and Papila, Çiğdem and Papila, Berrin and Sönmez Wetherilt, Ceyda and Demirci, Nebi Serkan and Alan, Özkan},
title = {Inflammatory and Nutritional Markers Predicting Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Multicenter Real-World Study},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {20},
pages = {7271},
doi = {10.3390/jcm14207271}
}
EUVIMED